The abundance of this protein is increased in the brains of individuals with DSAD, which may be associated with a decrease in Cathepsin B activity compared to individuals who have Alzheimer’s disease in the general population. This evidence concerns the gene CTSB and early-onset autosomal dominant Alzheimer disease.